- Supported exchanges /
- KO /
- 003220.KO
Daewon Pharm (003220 KO) stock market data APIs
Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 40 countries primarily in Asia, Central and South America, the Middle East, CIS, and Africa. The company was founded in 1958 and is headquartered in Seoul, South Korea.
Daewon Pharm Financial Data Overview
| 14590 | |
| 14540 | |
| - | |
| 14700 | |
| 14520 | |
| 13910-20700 | |
| 309 250 M | |
| 21 196 K | |
| 566 093 M | |
| 313.3136 | |
| 0.0203 | |
| 0.42 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Daewon Pharm Fundamental Data is available in our Financial Data APIs
- Net Revenue 566 093 M
- EBITDA 44 762 M
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Daewon Pharm Earnings via APIs
- Latest Release 2024-11-12
- EPS/Forecast NaN
Get Daewon Pharm End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
